Is Krsnaa Diagnostics a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Krsnaa Diagnostics Ltd is a average quality company .

Is Krsnaa Diagnostics undervalued or overvalued?

The key valuation ratios of Krsnaa Diagnostics Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone .

What is Krsnaa Diagnostics share price return in the past 10 years?

Data is not available for this company

Is Krsnaa Diagnostics a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Krsnaa Diagnostics Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

Krsnaa Diagnostics Ltd - Stock Valuation and Financial Performance

Name: Krsnaa Diagnostics
Brand: Krsnaa Diagnostics

BSE: 543328 | NSE: KRSNAA | Hospital & Healthcare Services | Small Cap

Place order

Krsnaa Diagnostics Share Price

₹746.60 -12.40 -1.63%
as on 06-Sep'24 16:01

10 Year X-Ray of Krsnaa Diagnostics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	0%	0%	0%	0%	0%	0%	0%	14.5%	11.8%	9.9%	-
Value Creation Index ⓘ	NA	NA	NA	NA	NA	NA	NA	0.0	-0.2	-0.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	455	487	620	650
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	7%	27.2%	-
Adj EPS ⓘ	0	0	0	0	0	0	0	21.8	19.7	17.6	18.6
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	-9.6%	-10.8%	-
BVPS (₹) ⓘ	0	0	0	0	0	0	0	217.3	234.4	250.1	255.6
Adj Net Profit ⓘ	0	0	0	0	0	0	0	68.6	62	56.9	60
Cash Flow from Ops. ⓘ	0	0	0	0	0	0	0	128	76.3	24.4	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0.3	0.4	6.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	27.2%
Adj EPS ⓘ	NA	NA	NA	-10.8%
BVPSⓘ	NA	NA	NA	6.7%
Share Price	-	-	-6.2%	9.4%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	10	8.7	7.4	7.4
Op. Profit Mgn % ⓘ	28.9	25.1	23.3	23.9
Net Profit Mgn % ⓘ	15.1	12.7	9.2	9.2
Debt to Equity ⓘ	0.1	0	0.2	-
Working Cap Days ⓘ	0	196	225	120
Cash Conv. Cycle ⓘ	0	-20	28	47

Recent Performance Summary

Sales growth is good in last 4 quarters at 26.82%

Return on Equity has declined versus last 3 years average to 7.40%

Sales growth has been subdued in last 3 years 0.00%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Krsnaa Diagnostics Ltd.

	Standalone	Consolidated
TTM EPS (₹)	19	18.6
TTM Sales (₹ Cr.)	621	650
BVPS (₹.) ⓘ	257.4	255.6
Reserves (₹ Cr.) ⓘ	815	809
P/BV ⓘ	2.91	2.93
PE ⓘ	39.38	40.27

From the Market
52 Week Low / High (₹)	527.55 / 788.60
All Time Low / High (₹)	354.00 / 1099.50
Market Cap (₹ Cr.)	2,421
Equity (₹ Cr.)	16.1
Face Value (₹)	5
Industry PE ⓘ	39.4

Management X-Ray of Krsnaa Diagnostics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Krsnaa Diagnostics

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Krsnaa Diagnostics

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'22	Mar'23	Mar'24
Sales	455	487	620
Operating Expenses ⓘ	324	365	475
Manufacturing Costs	135	108	90
Material Costs	60	74	141
Employee Cost	54	75	111
Other Costs ⓘ	75	108	133
Operating Profit ⓘ	131	122	144
Operating Profit Margin (%)	28.9%	25.1%	23.3%
Other Income ⓘ	15	19	17
Interest ⓘ	18	8	16
Depreciation ⓘ	41	54	75
Exceptional Items ⓘ	0	0	0
Profit Before Tax ⓘ	87	80	70
Tax ⓘ	18	18	13
Profit After Tax	68	62	57
PAT Margin (%)	15.0%	12.8%	9.2%
Adjusted EPS (₹)	21.8	19.8	17.6
Dividend Payout Ratio (%)	11%	14%	14%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	682	736	807
Share Capital ⓘ	16	16	16
Reserves ⓘ	667	720	791
Minority Interest	0	0	0
Debt	33	24	138
Long Term Debt	33	24	42
Short Term Debt	0	0	96
Trade Payables	77	62	82
Others Liabilities ⓘ	83	86	143
Total Liabilities ⓘ	875	909	1,170
Fixed Assets
Gross Block	491	627	874
Accumulated Depreciation	106	156	226
Net Fixed Assetsⓘ	386	471	647
CWIP ⓘ	28	25	10
Investmentsⓘ	0	0	0
Inventories	9	25	36
Trade Receivables	58	73	176
Cash Equivalents	242	109	54
Others Assetsⓘ	152	205	247
Total Assets ⓘ	875	909	1,170

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	128	76	24
PBT ⓘ	87	80	70
Adjustment ⓘ	49	45	70
Changes in Working Capital ⓘ	-1	-36	-97
Tax Paid ⓘ	-7	-13	-19
Cash Flow From Investing Activity ⓘ	-241	-109	-129
Capex	-131	-135	-193
Net Investments	-126	16	54
Others ⓘ	17	10	10
Cash Flow From Financing Activityⓘ	176	-33	84
Net Proceeds from Shares ⓘ	400	0	23
Net Proceeds from Borrowing ⓘ	-159	-9	-6
Interest Paid ⓘ	-16	-5	-12
Dividend Paid ⓘ	0	-8	-9
Others ⓘ	-48	-11	88
Net Cash Flow ⓘ	64	-66	-20

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	10.02	8.76	7.36
ROCE (%)	14.47	11.75	9.94
Asset Turnover Ratio	0.52	0.55	0.6
PAT to CFO Conversion(x)	1.88	1.23	0.42
Working Capital Days
Receivable Days	46	49	73
Inventory Days	7	13	18
Payable Days	468	343	187

Krsnaa Diagnostics Ltd Stock News

Krsnaa Diagnostics Ltd FAQs

What is the share price of Krsnaa Diagnostics?

Company share prices are keep on changing according to the market conditions. The closing price of Krsnaa Diagnostics on 06-Sep-2024 16:01 is ₹746.6.

What is the market cap of Krsnaa Diagnostics?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-Sep-2024 16:01 the market cap of Krsnaa Diagnostics stood at ₹2,421.3.

What is the P/E ratio of Krsnaa Diagnostics?

The latest P/E ratio of Krsnaa Diagnostics as of 06-Sep-2024 16:01 is 39.38.

What is the P/B ratio of Krsnaa Diagnostics?

The latest P/B ratio of Krsnaa Diagnostics as of 06-Sep-2024 16:01 is 2.91.

What is the 52-week high and low of Krsnaa Diagnostics?

The 52-week high of Krsnaa Diagnostics is ₹788.6 and the 52-week low is ₹527.5.

What is the TTM revenue of Krsnaa Diagnostics?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Krsnaa Diagnostics is ₹620.9 ( Cr.) .

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics is one of the largest differentiated diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology services to public and private hospitals, medical colleges and community health centres pan-India. It also operate one of India’s largest tele-radiology reporting hubs in Pune that is able to process large volumes of X-rays, CT scans and MRI scans round the clock and 365 days a year, and allows it to serve patients in remote locations where diagnostic facilities are limited. It provides quality and inclusive diagnostic services at affordable rates across various segments.

The company offers range of diagnostics imaging services and clinical laboratory tests that include both routine and specialized tests / studies and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases. Its diagnostic imaging/radiology services include conducting X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry and mammography. In its pathology segment, its primary focus includes biochemistry, haematology, clinical pathology, histopathology and cytopathology, microbiology, serology and immunology. A suite of diagnostic equipment is located at its tele-radiology hub along with a team of radiologists which provide it significant operating efficiencies and scalability.

Business area of the company

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.

Key awards, accreditations or recognitions

2016: Star of Asia Award for Health Excellence at the 10th International Seminar of the Indian Achievers Forum.
2017: Emerging Company Award for Health Excellence at the 42nd National Seminar of the Indian Achiever’s Awards.
2019: India’s Greatest Brands Award for Healthcare and Diagnostics by Asia One.
2020: Best Diagnostic and Imaging Centre of the Year (Asia) at the Asia Healthcare Summit and Awards.
2020: Best Diagnostics Service Company of the Year at the India Excellence Awards by ET Now.
2020: Outstanding Achievement Award in Healthcare Social Causes at the India Excellence Awards by ET Now.

Major events and milestones

2011: Incorporation of the company with two radiology centres.
2013: Started operating 12 centres in Himachal Pradesh in public private partnership.
2016: Investment by Somerset and Kitara in the Company.
2017: Completed installation of 50 centres in four states.
2018: Expanded operations across 13 states.
2019: Received accreditation from NABH for a centre in Madhya Pradesh.
2019: Investment by Phi Capital in the company.
2020 Received accreditation from NABH and NABL for certain centres in Maharashtra.
2020: Expanded to over 1,500 centres across India.
2020: Received accreditation from NABL for certain centres in Rajasthan.